Address
Pappas Ventures
Research Triangle Park
PO Box 110287
NC 27709
United States
Website
Recent investment activity
Tags
KANDO id: 3260
Funding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 63Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Marina Biotech | N/A | |||||
Nereus Pharmaceuticals Inc | N/A | |||||
NuVasive Inc | N/A | |||||
Nuvelo Inc | Optimize therapeutic outcomes for patients and their prescribing physicians. | N/A | ||||
Optherion Inc | N/A | |||||
Panacos Pharmaceuticals Inc | N/A | |||||
Peninsula Pharmaceuticals Inc | N/A | |||||
Plexigen | Diagnostic company focusing on instrumentation and service for a wide array of clinical testing. | N/A | ||||
Plexxikon Inc | N/A | |||||
Reprogenesis | A public company focused on regenerative medicine. | N/A | ||||
Selventa Inc | A personalized healthcare company helping pharmaceutical and biotechnology partners find optimal treatments for the right patients. | N/A | ||||
Sensys Medical | N/A | |||||
Signase | N/A | |||||
Spherics Inc | Pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles. | N/A | ||||
Syndax Pharmaceuticals Inc | A clinical development company focused on novel oral therapies for cancer. | N/A | ||||
Syntonix Pharmaceuticals Inc | A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into | N/A | ||||
TESARO Inc | N/A | |||||
TyRx Inc | N/A | |||||
TyRx Inc | N/A | |||||
UltraGenyx Pharmaceutical | N/A | |||||
X-Ceptor Therapeutics | N/A | |||||
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | ||||
Aclara Biosciences Inc | Develops and distributes assay solutions for drug discovery and development | N/A | ||||
Afferent Pharmaceuticals Inc | N/A | |||||
Anthera Pharmaceuticals Inc | N/A |